🇺🇸 FDA

Company profile · Sponsor

H.

H. Lundbeck A/S

E388D41 · EMA pharma Valby, DK
Pipeline
11
Drugs
0
Patents
0

Quick answer

H. (E388D41) is a pharma company. headquartered in Valby, DK. listed on EMA. NovaPharmaNews links 11 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E388D41
Exchange EMA
Company type pharma
Headquarters Valby, DK

Pipeline (11)

Search pipeline →

  1. VYEPTI 100 mg concentrate for solution for infusion

    H.

    Chronic migraine

    phase 3 small molecule active

    1 trial

  2. VYEPTI 100 mg concentrate for solution for infusion

    H.

    Migraine

    phase 3 small molecule active

    1 trial

  3. VYEPTI 100 mg concentrate for solution for infusion, Nacl 0.9%

    H.

    Migraine

    phase 3 small molecule active

    1 trial

  4. commercially available saline solution for infusion, Amlenetug 53 mg/ml solution for infusion

    H.

    Multiple System Atrophy

    phase 3 small molecule active

    1 trial

  5. A Phase II, multi-site, open-label, dose-titration trial to investigate the safety, tolerability, pharmacokinetics, and efficacy of Lu AG13909 in adults with Cushing’s disease

    H.

    Cushing's Disease

    phase 2 other active

    1 trial

  6. Placebo to match IMP Lu AG09222

    H.

    Migraine

    phase 2 small molecule active

    1 trial

  7. A study to test the safety and tolerability of Lu AH69593 in adults that are healthy or have narcolepsy.

    H.

    Narcolepsy

    phase 1 other active

    1 trial

  8. A trial to test the safety and tolerability of Lu AH70212 and Lu AH69593 in healthy adults.

    H.

    Narcolepsy

    phase 1 other active

    1 trial

  9. Interventional, open-label, single-group, long-term follow-up trial of Lu AG22515 in patients with moderate-to-severe Thyroid Eye Disease

    H.

    Active, moderate-to-severe TED

    phase 1 other active

    1 trial

  10. Lu AF28996 in Patients With Parkinson's Disease

    H.

    Parkinson's Disease

    phase 1 other active

    1 trial

  11. VYEPTI 100 mg concentrate for solution for infusion

    H.

    Chronic Migrane, Migrane, Medication Overuse Headache

    approved small molecule active

    1 trial

Frequently asked questions

What is H.?

H. (E388D41) is a pharma company. headquartered in Valby, DK. listed on EMA. NovaPharmaNews links 11 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does H. sponsor?

We track 11 ClinicalTrials.gov-linked programs for H., including VYEPTI 100 mg concentrate for solution for infusion and 10 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does H. company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.